...业致富项目 酶基因(cathepsin,v-cath)、几丁质酶基因(chitinase,chiA)、gp37、酪蛋白磷酸酶基因(protein tyrosine phosphatase 2,ptp2)、脱皮甾体尿苷二磷酸葡萄糖基转移酶基因(ecdysteroid UDP glucosyl trans..
基于2个网页-相关网页
...业致富项目 酶基因(cathepsin,v-cath)、几丁质酶基因(chitinase,chiA)、gp37、酪蛋白磷酸酶基因(protein tyrosine phosphatase 2,ptp2)、脱皮甾体尿苷二磷酸葡萄糖基转移酶基因(ecdysteroid UDP glucosyl trans..
基于2个网页-相关网页
protein tyrosine Phosphatase PTP-2 线虫蛋白质酪氨酸磷酸酶PTP
protein tyrosine phosphatase shp 2 蛋白酪氨酸磷酸酶shp
protein tyrosine phosphatase-like IA-2 autoantibody 酪氨酸磷酸酶抗体
Objective: To study relation between protein tyrosine phosphatase 1b (PTP-1B) with type 2 diabetes and metabolic syndrome (MS).
目的研究蛋白酪氨酸磷酸酶- 1 B (PTP - 1b)与2型糖尿病及代谢综合征(MS)之间的关系。
The roles of protein tyrosine phosphatase SHP 2 in breast cancer (MCF 7) cell adhesion and migration were investigated.
探讨蛋白酪氨酸磷酸酶SHP 2在乳腺癌细胞MCF 7的移动及粘附中的作用。
The bromophenol compounds of the invention have inhibitory activity against protein tyrosine phosphatase (PTP1B), and can be used for treating the type 2 diabetes and the obesity.
本发明中的溴酚类化合物具有蛋白质酪氨酸磷酸酯酶(PTP1B)抑制活性，可用于治疗2型糖尿病和肥胖症。
应用推荐